Etoposide and Squamous cell carcinoma - a phase IV clinical study of FDA data

Summary:

Squamous cell carcinoma is found among people who take Etoposide, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Etoposide and have Squamous cell carcinoma. It is created by eHealthMe based on reports of 63,043 people who have side effects when taking Etoposide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

63,043 people reported to have side effects when taking Etoposide.
Among them, 36 people (0.06%) have Squamous cell carcinoma.


What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 63,102 Etoposide users for its effectiveness, alternative drugs and more.

What is Squamous cell carcinoma?

Squamous cell carcinoma (a cancer of a kind of epithelial cell) is found to be associated with 1,271 drugs and 777 conditions by eHealthMe.

Number of Etoposide and Squamous cell carcinoma reports submitted per year:

Could Etoposide cause Squamous cell carcinoma?

Time on Etoposide when people have Squamous cell carcinoma *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Squamous cell carcinoma when taking Etoposide *:

  • female: 11.76 %
  • male: 88.24 %

Age of people who have Squamous cell carcinoma when taking Etoposide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 6.25 %
  • 20-29: 18.75 %
  • 30-39: 6.25 %
  • 40-49: 6.25 %
  • 50-59: 6.25 %
  • 60+: 56.25 %

Common drugs people take besides Etoposide *:

  1. Bicnu: 14 people, 38.89%
  2. Methotrexate: 6 people, 16.67%
  3. Cyclophosphamide: 5 people, 13.89%
  4. Cytarabine: 4 people, 11.11%
  5. Alkeran: 4 people, 11.11%
  6. Prednisolone: 3 people, 8.33%
  7. Cisplatin: 3 people, 8.33%
  8. Vincristine Sulfate: 3 people, 8.33%
  9. Prednisone: 2 people, 5.56%
  10. Rituxan: 2 people, 5.56%

Common side effects people have besides Squamous cell carcinoma *:

  1. Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 18 people, 50.00%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 17 people, 47.22%
  3. Infection: 16 people, 44.44%
  4. Fatigue (feeling of tiredness): 16 people, 44.44%
  5. Thyroid Cancer: 16 people, 44.44%
  6. Idiopathic Pulmonary Fibrosis (chronic lung disease): 16 people, 44.44%
  7. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 16 people, 44.44%
  8. Herpes Zoster: 16 people, 44.44%
  9. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 16 people, 44.44%
  10. Fungal Infection: 16 people, 44.44%

Common conditions people have *:

  1. B-Cell Lymphoma Recurrent (blood cancer affecting b cells-recurrent): 14 people, 38.89%
  2. B-Cell Lymphoma Refractory (blood cancer affecting b cells-relapsed): 12 people, 33.33%
  3. Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 16.67%
  4. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.33%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 8.33%
  6. Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 5.56%
  7. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 5.56%
  8. Skin Cancer: 1 person, 2.78%
  9. Neuroendocrine Carcinoma Of The Skin (a rare type of cancer that forms on or just beneath the skin, usually in parts of the body that have been exposed to the sun): 1 person, 2.78%
  10. Multiple Myeloma (cancer of the plasma cells): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Squamous cell carcinoma?

Check whether Squamous cell carcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Squamous cell carcinoma and when was it recovered:

Expand to all the drugs that have ingredients of etoposide:

Alternative drugs to, pros and cons of Etoposide:

Common Etoposide side effects:

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Squamous cell carcinoma treatments and more:

COVID vaccines that are related to Squamous cell carcinoma:

Common drugs associated with Squamous cell carcinoma:

All the drugs that are associated with Squamous cell carcinoma:

Common conditions associated with Squamous cell carcinoma:

All the conditions that are associated with Squamous cell carcinoma:

How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: